GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Fos | rn6_v1_chr6_+_109300433_109300433 | 0.48 | 2.9e-20 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_70626252 Show fit | 72.32 |
ENSRNOT00000036947
|
laminin subunit gamma 2 |
|
chr13_-_70625842 Show fit | 67.61 |
ENSRNOT00000092499
|
laminin subunit gamma 2 |
|
chr1_+_79989019 Show fit | 57.47 |
ENSRNOT00000020428
|
dystrophia myotonica-protein kinase |
|
chr16_-_18766174 Show fit | 37.49 |
ENSRNOT00000084813
|
surfactant protein D |
|
chr10_-_88122233 Show fit | 32.80 |
ENSRNOT00000083895
ENSRNOT00000005285 |
keratin 14 |
|
chr3_-_92749121 Show fit | 32.65 |
ENSRNOT00000008760
|
CD44 molecule (Indian blood group) |
|
chr16_-_10941414 Show fit | 29.96 |
ENSRNOT00000086627
ENSRNOT00000085414 ENSRNOT00000081631 ENSRNOT00000087521 ENSRNOT00000083623 |
LIM domain binding 3 |
|
chr5_+_164796185 Show fit | 29.29 |
ENSRNOT00000010779
|
natriuretic peptide B |
|
chr1_+_199555722 Show fit | 28.74 |
ENSRNOT00000054983
|
integrin subunit alpha X |
|
chr18_+_3861539 Show fit | 28.13 |
ENSRNOT00000015363
|
laminin subunit alpha 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 139.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
14.9 | 74.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 68.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
3.1 | 66.0 | GO:0031424 | keratinization(GO:0031424) |
3.1 | 55.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 54.4 | GO:0030239 | myofibril assembly(GO:0030239) |
4.4 | 43.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
12.9 | 38.6 | GO:1904178 | sterol regulatory element binding protein import into nucleus(GO:0035105) negative regulation of adipose tissue development(GO:1904178) |
7.5 | 37.5 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
0.2 | 34.6 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.4 | 153.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.0 | 74.2 | GO:0045095 | keratin filament(GO:0045095) |
0.5 | 70.8 | GO:0030018 | Z disc(GO:0030018) |
1.4 | 60.5 | GO:0043034 | costamere(GO:0043034) |
2.1 | 57.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 48.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
4.8 | 38.6 | GO:0005638 | lamin filament(GO:0005638) |
2.9 | 38.3 | GO:0031143 | pseudopodium(GO:0031143) |
1.1 | 37.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.7 | 37.1 | GO:0034707 | chloride channel complex(GO:0034707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 166.7 | GO:0008201 | heparin binding(GO:0008201) |
0.9 | 58.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.3 | 50.0 | GO:0051015 | actin filament binding(GO:0051015) |
1.7 | 46.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
6.2 | 43.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 38.2 | GO:0005198 | structural molecule activity(GO:0005198) |
1.5 | 37.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
6.6 | 32.8 | GO:1990254 | keratin filament binding(GO:1990254) |
3.3 | 32.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.9 | 30.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 181.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 61.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 49.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.0 | 44.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 42.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 36.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.8 | 32.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 28.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.7 | 24.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 22.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 180.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 44.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 43.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.8 | 37.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.5 | 32.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 27.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 25.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.0 | 24.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 22.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 20.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |